Psychedelic Research in 2022

No matter what happens with stock prices or the economy, one thing is certain… Companies (and individuals) will never stop conducting the necessary research on psychedelic compounds.

This past year was no exception. One could even argue that 2022 proved to be the most progressive when it comes to progressing clinical trials and unveiling success stories that need to be heard.

The potential is clear and ready to be realized. How will psychedelic research further progress in 2023?